OMERS ADMINISTRATION Corp boosted its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 54.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 310,616 shares of the semiconductor company's stock after buying an additional 109,785 shares during the quarter. Synopsys makes up about 1.3% of OMERS ADMINISTRATION Corp's holdings, making the stock its 23rd largest position. OMERS ADMINISTRATION Corp owned about 0.20% of Synopsys worth $150,761,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of SNPS. Wealth Enhancement Advisory Services LLC increased its position in Synopsys by 1.4% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 18,998 shares of the semiconductor company's stock worth $9,620,000 after buying an additional 264 shares during the last quarter. Harbor Capital Advisors Inc. boosted its holdings in shares of Synopsys by 2.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,691 shares of the semiconductor company's stock worth $821,000 after acquiring an additional 41 shares during the period. Czech National Bank boosted its holdings in shares of Synopsys by 6.7% in the fourth quarter. Czech National Bank now owns 33,307 shares of the semiconductor company's stock worth $16,166,000 after acquiring an additional 2,096 shares during the period. Kieckhefer Group LLC bought a new position in shares of Synopsys in the fourth quarter worth $27,000. Finally, Talbot Financial LLC boosted its holdings in shares of Synopsys by 3.1% in the fourth quarter. Talbot Financial LLC now owns 24,083 shares of the semiconductor company's stock worth $11,689,000 after acquiring an additional 728 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Trading Down 0.0%
Shares of SNPS traded down $0.05 during midday trading on Friday, reaching $514.43. The stock had a trading volume of 946,601 shares, compared to its average volume of 1,107,910. The company has a market capitalization of $79.54 billion, a price-to-earnings ratio of 35.43, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16. The company's 50-day moving average is $444.44 and its 200 day moving average is $489.13. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $624.80.
Wall Street Analysts Forecast Growth
SNPS has been the subject of a number of analyst reports. Needham & Company LLC reaffirmed a "buy" rating and issued a $650.00 price target on shares of Synopsys in a report on Thursday, February 27th. Wells Fargo & Company cut their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a report on Thursday, February 27th. Bank of America cut their price target on Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a report on Wednesday, April 16th. Mizuho cut their price target on Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a report on Tuesday, April 15th. Finally, KeyCorp cut their price target on Synopsys from $690.00 to $555.00 and set an "overweight" rating for the company in a report on Tuesday, April 15th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $613.43.
Check Out Our Latest Research Report on SNPS
Insider Activity
In other news, insider Geus Aart De sold 15,705 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the transaction, the insider now directly owns 116,671 shares in the company, valued at approximately $51,850,925.82. This represents a 11.86% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares in the company, valued at $32,890,077.50. This trade represents a 13.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company's stock.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.